On 4 November 2021, the Agency submitted to the Commission an opinion [ECHA opinion of 13 October 2021 on the Union authorisation of ‘Bioquell HPV-AQ’ (ECHA/BPC/296/2021), https://echa.europa.eu/bpc-opinions-on-union-authorisation], the draft summary of the biocidal product characteristics (‘SPC’) of ‘Bioquell HPV-AQ’ and the final assessment report on the single biocidal product in accordance with Article 44(3) of Regulation (EU) No 528/2012.
Recital 4, Regulation (EU) 2022/1226
In forcesince 14 Jul 2022